The European Union is ready to help drug companies expand coronavirus vaccine production to clear a "bottleneck" in distribution, its top health official said today.
Health commissioner Stella Kyriakides told German news agency DPA that any delay in getting approved vaccines out was down to production capacity shortage, not EU planning. "The bottleneck at the moment is not the volume of orders but the worldwide shortage of production capacity," she said, in comments distributed by her office.
Ms Kyriakides noted that Brussels had provided €100 million to German firm BioNTech, which developed a vaccine with US giant Pfizer, to help build production capacity.